Small Molecule Bioanalysis, Large Molecule Bioanalysis

Small Molecule and Large Molecule Bioanalysis

Precise small molecule and large molecule bioanalysis entail robust quantitation of drug compounds and biomarkers. Our veteran team has an excellent track record of advancing the critical PK, BA/BE, TK, immunogenicity, biomarker, and custom bioanalytical assays across discovery, preclinical, and clinical studies. We offer small molecule bioanalysis and large molecule bioanalysis such as method development, validation, and sample analysis in R&D and GLP/GCP setting using LC-MS/MS, ELISA, MSD, qPCR, Western Blot, and Luminex, among other technologies.

Small and Large Molecule Bioanalysis: LC-MS/MS, ELISA, MSD, qPCR, Western Blot, and Luminex

NorthEast BioLab has earned a deep-rooted reputation for small molecule bioanalysis since our founding in 2003. In this regard, we have efficiently delivered numerous biotech and pharmaceutical research studies on platforms such as LC-MS/MS, HPLC/FL, and HPLC/UV. Fast forward to today, we aim to continue our leadership within bioanalytical sciences as per our foundational principles. To that end, we have further broadened our scientific expertise by making significant strides towards biologics bioanalysis over the past few years.

Specifically, we have meaningfully extended our custom assay capabilities for large molecule bioanalysis through enzyme-linked immunosorbent assay (“ELISA”). Although ELISA assays were first developed in the 1970s, advances in digitization and automation have since improved their sensitivity and throughput dramatically. Consequentially, these gold-standard assays have become known for their diverse and optimal applications. Fast forward to today, we utilize MSD, qPCR, Western Blot, and Luminex, and other modern bioanalysis techniques for the promising future of biotech and pharmaceutical research.

15+ Years of Small and Large Molecule Bioanalysis with Top Biotech and Pharma

Our scientists, at NorthEast BioLab, share a passion for facilitating cutting-edge treatments of life-threatening diseases. Thus, we continue to drive high-quality, innovative drug development and research. Additionally, we persistently strive to fulfill biotech and pharmaceutical research needs to the satisfaction of our clients. As a result, we sometimes opportunistically enhance our solutions to address the fast pace of change in science and medicine.

Put differently, we are known for our client-centric approach toward building partnerships and overcoming obstacles during drug development. Furthermore, we maintain a 100% process transparency that is uniformly appreciated by all our clients. Mostly, we take on ourselves to collaborate with internal teams and other vendors to achieve our shared goals and explore the uncharted territories. When permitted, this delivery approach has regularly opened quite a few doors of opportunities for our clients.

Ultimately, NorthEast BioLab thrives on the mission of realizing and reaching the maximum potential of each internal or external team member. Among other advantages, our narrow focus on your biotech and pharmaceutical research allows us to make your company’s drug development program successful. All we request is that you try us to experience our first-class services – notably discovery, preclinical, and clinical development bioanalysis.